Reversal of bone marrow fibrosis in idiopathic myelofibrosis after treatment with α-interferon

被引:0
作者
Domingues, MA
Hæpers, ATC
Massaut, IHB
Vassallo, J
Lorand-Metze, I
机构
[1] State Univ Campinas, Fac Med, Campinas, SP, Brazil
[2] Hematol Hemotherapy Ctr Florianopolis, Florianopolis, SC, Brazil
关键词
myelofibrosis; children; interferon; treatment;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 14-year-old boy presenting with primary myelofibrosis (MMM) was treated with alpha-interferon (IFN). After 6 months his spleen was no longer palpable and blood counts had returned to normal. A reversal of bone marrow fibrosis was histologically documented. Although improvement in symptoms and blood counts has been reported, this is only the second description of reversal of bone marrow fibrosis in MMM after treatment.
引用
收藏
页码:1124 / 1125
页数:2
相关论文
共 50 条
  • [31] Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
    Kvasnicka, Hans Michael
    Thiele, Juergen
    Bueso-Ramos, Carlos E.
    Sun, William
    Cortes, Jorge
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [32] Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
    Hans Michael Kvasnicka
    Jürgen Thiele
    Carlos E. Bueso-Ramos
    William Sun
    Jorge Cortes
    Hagop M. Kantarjian
    Srdan Verstovsek
    Journal of Hematology & Oncology, 11
  • [33] Disappearance of fibrosis in secondary myelofibrosis after ruxolitinib treatment: new endpoint to achieve?
    Molica, Matteo
    Serrao, Alessandra
    Saracino, Roberta
    Zacheo, Irene
    Stingone, Christof
    Alimena, Giuliana
    Breccia, Massimo
    ANNALS OF HEMATOLOGY, 2014, 93 (11) : 1951 - 1952
  • [34] Effective and safe interferon treatment for Japanese patients with chronic myelogenous leukemia relapse after bone marrow transplantation
    Sao, H
    Kato, C
    Kitaori, K
    Adachi, T
    Yano, K
    Kobayashi, M
    Kojima, H
    Tanimoto, M
    Hirabayashi, N
    Minami, S
    Yamada, H
    Morishita, Y
    Morishima, Y
    Kodera, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2000, 72 (02) : 237 - 242
  • [35] Danazol treatment of idiopathic myelofibrosis with severe anemia
    Cervantes, F
    Hernández-Boluda, JC
    Alvarez, A
    Nadal, E
    Montserrat, E
    HAEMATOLOGICA, 2000, 85 (06) : 595 - 599
  • [36] Morphological and Immunophenotypical Changes of Human Bone Marrow Adipocytes in Marrow Metastasis and Myelofibrosis
    Venti, Michele Dello Spedale
    Palmisano, Biagio
    Donsante, Samantha
    Farinacci, Giorgia
    Adotti, Flavia
    Coletta, Ilenia
    Serafini, Marta
    Corsi, Alessandro
    Riminucci, Mara
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [37] Quantitative MRI reveals heterogeneous impacts of treatment on diseased bone marrow in a mouse model of myelofibrosis
    Robison, Tanner H.
    Lee, Winston
    Luker, Kathryn E.
    Pettit, Kristen
    Talpaz, Moshe
    Chenevert, Thomas L.
    Ross, Brian D.
    Luker, Gary D.
    MAGNETIC RESONANCE IN MEDICINE, 2024, 91 (06) : 2568 - 2578
  • [38] Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosis
    Fazzi, R
    Pacini, S
    Testi, R
    Azzarà, A
    Galimberti, S
    Testi, C
    Trombi, L
    Metelli, MR
    Petrini, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (01) : 76 - 85
  • [39] Metastatic splenic angiosarcoma presenting with anemia and bone marrow fibrosis mimicking primary myelofibrosis: A case report and literature review
    Wu, Meiqing
    Li, Zhongqing
    Luo, Lin
    Zhao, Weihua
    Luo, Jun
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (02)
  • [40] Polycythaemia vera:: bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan
    Kreft, A
    Nolde, G
    Büsche, G
    Buhr, T
    Kreipe, H
    Georgii, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 64 (01) : 32 - 41